A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Clinical trial NCT00116909 · COMPLETED

Trial details

NCT number: NCT00116909
Sponsor: OSI Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Recurrent or Metastatic Cancer of the Head and Neck Must Have Failed First-Line Therapy

Start date: 2004-08-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.